Laura Chico
Stock Analyst at Wedbush
(0)
# 4368
Out of 5,344 analysts
257
Total ratings
30.61%
Success rate
-11.51%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VIGL Vigil Neuroscience | Downgrades: Neutral | 13 8 | 7.89 | 1.39% | 11 | May 22, 2025 | |
TVTX Travere Therapeutics | Reiterates: Outperform | 30 30 | 15.85 | 89.27% | 11 | May 16, 2025 | |
GOSS Gossamer Bio | Reiterates: Outperform | 4 4 | 1.19 | 236.13% | 5 | May 16, 2025 | |
SLDB Solid Biosciences | Maintains: Outperform | 18 17 | 2.81 | 504.98% | 2 | May 16, 2025 | |
JBIO Jade Biosciences | Reiterates: Outperform | 17 17 | n/a | n/a | 2 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 4 | 3.06 | 30.72% | 4 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 30 | 13.44 | 123.21% | 8 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 34 26 | 19.64 | 32.38% | 8 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 26 28 | 37.56 | -25.45% | 7 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 43 43 | 14.25 | 201.75% | 10 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 43 | 15.34 | 180.31% | 2 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 3 | 0.29 | 934.48% | 2 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 36 36 | 18.44 | 95.23% | 6 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 28 | 3.92 | 614.29% | 9 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 29 | 17.48 | 65.9% | 14 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 6 6 | 6.54 | -8.26% | 9 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 157 147 | 120.19 | 22.31% | 9 | Feb 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 46 48 | 35.7 | 34.45% | 12 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 12 | 1.46 | 721.92% | 10 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 1.86 | 1082.8% | 1 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 210 205 | 125.84 | 62.91% | 16 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 44 | n/a | n/a | 7 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 49 | 29.73 | 64.82% | 8 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 8 7 | 2.91 | 140.55% | 4 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 11 11 | 3.98 | 176.38% | 13 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 42 42 | 13.57 | 209.51% | 7 | Jul 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 17 17 | 9.38 | 81.24% | 6 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 1435 1435 | n/a | n/a | 3 | Jun 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 31 | 15.93 | 94.6% | 5 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 11 | 0.33 | 3233.33% | 4 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 | 3.85 | 29.87% | 5 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 330 | n/a | n/a | 6 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 5 | Sep 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 42 | n/a | n/a | 3 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 5 | n/a | n/a | 2 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 5 | 2.75 | 81.82% | 2 | Aug 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 149 | 15.67 | 847.67% | 1 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | n/a | n/a | 1 | Sep 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Feb 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 33 | n/a | n/a | 1 | Sep 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 40 | n/a | n/a | 3 | Feb 15, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 240 0 | n/a | n/a | 2 | Sep 12, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 36 0 | n/a | n/a | 2 | Mar 2, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 720 | 7.38 | 9656.1% | 1 | Jan 19, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 1 | Nov 16, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Strong Buy | 280 | 24.48 | 1043.79% | 1 | Apr 21, 2017 |